Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Globalizing the Scientific Bandwagon: Trajectories of Precision Medicine in China and Brazil

Texto completo
Autor(es):
Au, Larry [1] ; da Silva, Renan Goncalves Leonel [2]
Número total de Autores: 2
Afiliação do(s) autor(es):
[1] Columbia Univ, Dept Sociol, 606 W 122nd St, New York, NY 10027 - USA
[2] Univ Sao Paulo, Fac Med, Sci & Technol Studies, Sao Paulo - Brazil
Número total de Afiliações: 2
Tipo de documento: Artigo Científico
Fonte: SCIENCE TECHNOLOGY & HUMAN VALUES; v. 46, n. 1 JUN 2020.
Citações Web of Science: 1
Resumo

Precision medicine (PM) is emerging as a scientific bandwagon within the contemporary biomedical sciences in the United States. PM brings together concepts and tools from genomics and bioinformatics to develop better diagnostics and therapies based on individualized information. Developing countries like China and Brazil have also begun pursuing PM projects, motivated by a desire to claim genomic sovereignty over its population. In spite of commonalities, institutional arrangements produced by the history of genomics research in China and Brazil are ushering PM along different trajectories. In the Chinese case, we identify a strong state-backed push for PM combined with a dynamic network of international academic and private actors along the lines of networked technonationalism that has made large-scale, speculative PM projects possible. The Brazilian case is characterized by an institutional void at the federal level in which PM is driven by domestic academic actors in universities in the regional level, resulting in smaller scale, needs-driven PM projects. Through these cases, this paper shows how a scientific bandwagon adapts to national histories and institutions. Through this peripheral translation of the scientific bandwagon, the global infrastructure of biomedical knowledge has the potential to be transformed. (AU)

Processo FAPESP: 17/18500-0 - A dinâmica de inovação na indústria biofarmacêutica: novas teorias sobre mudança tecnológica no desenvolvimento de anticorpos monoclonais
Beneficiário:Renan Gonçalves Leonel da Silva
Modalidade de apoio: Bolsas no Exterior - Estágio de Pesquisa - Pós-Doutorado
Processo FAPESP: 15/24133-5 - A Política Científica, Tecnológica e de Inovação em Saúde no Brasil: o papel do arcabouço político-institucional no desenvolvimento da pesquisa em Anticorpos Monoclonais.
Beneficiário:Renan Gonçalves Leonel da Silva
Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado